Navigation Links
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2a Cellulite Study of Collegenase Clostridium Histolyticum
Date:10/23/2013

treatments are beneficial.[iv]

"Cellulite can affect the appearance of women's skin, causing undue bother and self-consciousness in some women," said Dr. James Tursi, Chief Medical Officer at Auxilium.  "With many current treatment options not showing benefit and with no FDA approved options, we believe that CCH, if successful in clinical trials, could lead to the first FDA-approved, office-based biological treatment option for cellulite that is supported by scientific results.  We look forward to increasing our understanding of the use of CCH for this common disorder."

The Phase 2a study is a randomized, double-blind multiple-dose study that is expected to enroll approximately 144 women between the ages of 18 and 45 in the United States.  Treatment effectiveness will be evaluated by investigator and patient assessments, as well as 3-D photographic imaging techniques.  Safety will be evaluated through the collection of adverse events.  To qualify for the study, participants must have EFP in the posterolateral thighs and/or buttocks for at least 12 months prior to a screening visit.  Each subject may receive up to three treatment sessions of study drug according to randomization and each treatment session will be approximately 21 days apart.  In this study, only the dimples treated on Day 1 may be retreated on Day 22 (Treatment Session 2) and Day 43 (Treatment Session 3) if, in the opinion of the investigator, the dimple continues to be evident.  A variable number of dimples may be treated within one treatment quadrant.

Following screening and determination of eligibility, study participants will be assigned to one of four groups that vary in treatment dose (low, medium, high, and placebo).  Subjects will be randomized to low-dose CCH, mid-dose CCH, high-dose CCH, or placebo in a 5:5:5:3 ratio.  Total treatment doses per treatment session inc
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Fla. , Nov. 25, 2014  Breckenridge ... into a multi-product ANDA agreement with Pii (Pharmaceutics ... ) under which Breckenridge and Pii expect to ... terms of the agreement, Pii will develop, manufacture ... and distribute the products under its own label.  ...
(Date:11/26/2014)... Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the ... conferences.  , 31 st NASDAQ Investor Program ... 2014 at 6:45 a.m. EST / 11:45 a.m. GMT. Iain ... provide an overview of the company and a business and financial ... in New York, NY on Tuesday, December ...
(Date:11/26/2014)... Nov. 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Healthcare Conference in New York on ... . Dr. Helen Torley , President and Chief ... presentation will be webcast through the "Investors" section of Halozyme,s ... be made available for 90 days following the event. To ...
Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... , ST. LOUIS, Dec. 22 KV Pharmaceutical Company ... Exchange (the "Exchange") for its securities to continue to trade on ... Annual Report on Form 10-K for the Company,s fiscal year ended ... the Company is unable to file the 2009 Annual Report on ...
... Dec. 22 On the morning of December 17, 2009, ... the center,s 10,000th patient, an 81-year-old male with a tumor deep ... impossible. Gamma Knife surgery is performed using Elekta,s Leksell Gamma Knife ... precisely on brain tumors and other targets in the head. ...
Cached Medicine Technology:KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 2KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 3KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 4KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 5KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 6KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 7University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System 2University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System 3University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System 4
(Date:11/26/2014)... The Deptford Center for Rehabilitation ... partnership designed to improve the quality of life ... (CHF) patients in the South Jersey area. Working ... team will help CHF patients manage their condition ... pairs the Cardiac Recovery program at the Deptford ...
(Date:11/26/2014)... November 26, 2014 German scientists say ... science can cause mesothelioma that looks and acts similar ... new article on the research. Click here to ... Institute for Toxicology and Experimental Medicine in Hannover injected ... all of the rats eventually developed mesothelioma , ...
(Date:11/26/2014)... 26, 2014 Loffler Companies has been ... in Imaging, an online information and news publication for ... the sixth consecutive year Loffler has earned this prestigious ... The Elite Dealer Awards honor the best and the ... Elite Dealer honorees were chosen for their innovative marketing ...
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance ... organization providing the adult demographic education and access ... navigate the rough seas of applying for Medicaid. Part ... the topic of Medicaid eligibility and proper planning, while ... applying for this coverage. , Senior Planning Services ...
(Date:11/26/2014)... Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with ... sales(at)researchmoz(dot)us , Researchmoz.us announces a new research report ... deep study of the report on the diabetes topic ... The global glucose monitoring market has a growth rate ... diabetics in the world. Their numbers have prompted the ...
Breaking Medicine News(10 mins):Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3
... Vitamins, Allows Class Participants to Download Free Weekly Classes at Oprah.com and ... ... March 31 Starting April 1,consumers who miss Oprah Winfrey and Eckhart ... can download,the event for free at Oprah.com or iTunes sponsored by new ...
... March 31 The American Stock Exchange(R),(Amex(R)) opened trading on ... Select Sector Index., Priced at $10.00 per unit with ... the ticker symbol HSJ and has a maturity,date of June ... The Amex specialist unit is,Wolverine Trading LLP., If you ...
... 31, 2008 /PRNewswire-FirstCall/ - Conseco, Inc.,(NYSE: CNO ) ... "As we stated when we issued preliminary results, ... Conseco for future profitable growth,",CEO Jim Prieur said. "New ... to be strong, and the expected future margins related ...
... PALO ALTO, Calif., March 31, 2008 ... 200-MS Series of ion trap,mass spectrometers for ... analytical chemists for the detection and characterization ... applications including,environmental, toxicology, food safety and agriculture. ...
... Parenthood, the Komen,Foundation is defeating its own mission of ... Life League denounced the claims made,in a recent Waco ... and "specious." The billboard ad draws a direct,connection between ... Waco,affiliate of Susan G. Komen for the Cure would ...
... 31 Varian, Inc.,(NasdaqGS: VARI) announced today the ... family of high performance gas chromatographs and application ... gas chromatograph models,and an associated range of analyzers ... applications. These new systems allow chemists,and engineers to ...
Cached Medicine News:Health News:Nature Made(R) Liquid Softgels Help Fuel Oprah's 'A New Earth' Web Event 2Health News:Conseco Reports Fourth Quarter and Year-End Results 2Health News:Conseco Reports Fourth Quarter and Year-End Results 3Health News:Conseco Reports Fourth Quarter and Year-End Results 4Health News:Conseco Reports Fourth Quarter and Year-End Results 5Health News:Conseco Reports Fourth Quarter and Year-End Results 6Health News:Conseco Reports Fourth Quarter and Year-End Results 7Health News:Conseco Reports Fourth Quarter and Year-End Results 8Health News:Conseco Reports Fourth Quarter and Year-End Results 9Health News:Conseco Reports Fourth Quarter and Year-End Results 10Health News:Conseco Reports Fourth Quarter and Year-End Results 11Health News:Conseco Reports Fourth Quarter and Year-End Results 12Health News:Conseco Reports Fourth Quarter and Year-End Results 13Health News:Conseco Reports Fourth Quarter and Year-End Results 14Health News:Conseco Reports Fourth Quarter and Year-End Results 15Health News:Conseco Reports Fourth Quarter and Year-End Results 16Health News:Conseco Reports Fourth Quarter and Year-End Results 17Health News:Conseco Reports Fourth Quarter and Year-End Results 18Health News:New Ion Trap Mass Spectrometers From Varian, Inc. Offer the Ultimate in Sensitive Detection and High Productivity 2Health News:Komen Foundation Support of Planned Parenthood 'Self-Defeating' 2Health News:New High Performance Gas Chromatographs and Analysis Solutions From Varian, Inc. Offer Enhanced Performance and Capabilities for More Applications 2Health News:New High Performance Gas Chromatographs and Analysis Solutions From Varian, Inc. Offer Enhanced Performance and Capabilities for More Applications 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: